Key facts
- In Capital is a other based in Beijing, China with 9 tracked portfolio companies.
- Notable positions include Zenshine Pharmaceuticals (Nanjing) Group, Immunofoco Biotechnology, Gen House, Mingyi Zhudao, Gyenno Science.
About In Capital
In Capital is a venture capital firm based in Beijing, China. The firm seeks to invest in companies based in China with sectors that include - medical services, medical instruments, biomedicine, In vitro diagnosis and smart medical devices including artificial intelligence, big data, internet of things and robots.
Free account
See the whole book
- ·Watchlist + alerts for In Capital's activity
Create free account
No card required
Portfolio, priced
9 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Zenshine Pharmaceuticals (Nanjing) Group | — | $354.4M | — | |
| Immunofoco Biotechnology | — | $298.1M | — | |
| Gen House | — | $268.3M | — | |
| Mingyi Zhudao | — | $37.6M | — | |
| Gyenno Science | — | $21.2M | — | |
| Heal- III | — | $6.3M | — | |
| Sandt Inspection | — | — | — | |
| Vitalgen | — | — | — | |
| Kossel Medtech | — | — | — |
Frequently asked
- What companies does In Capital invest in?
- In Capital has 9 recorded portfolio companies, including Zenshine Pharmaceuticals (Nanjing) Group, Immunofoco Biotechnology, Gen House, Mingyi Zhudao.